Pharmaniaga seen as among frontrunners for vaccine tender


MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

PETALING JAYA: Positive developments in the development of a Covid-19 vaccine will continue to lift interest in local pharmaceutical manufacturers, including Pharmaniaga Bhd, which is touted to be among the frontrunners to win a tender for the vaccine.

MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Oharmaniaga , vaccine , frontrunners , Doupharma ,

   

Next In Business News

Ringgit opens higher as US$ weakens post-NFP data
Bursa Malaysia drifts sideways as investors await start of US election
Trading ideas: SD Guthrie, Dayang, Datasonic, Elridge, Genetec, MN, Bina Puri, Bintai Kinden, MCE, BHIC, Carimin, Tuju Setia, Khee San
Wall St slips as uncertainty surrounds U.S. election
Oil jumps nearly 3% after Opec+ delays output hike, US election in focus
Datasonic acquires 51% stake in ICT firm
High real estate credit growth raises concern
Elridge Energy inks 15-year biomass fuel deal
Bumi Armada’s North Sea contract win to lift earnings
US election may impact US$89bil worth of exports

Others Also Read